
What's the Difference Between Seborrheic Keratosis and Actinic Keratosis?
Actinic keratosis and seborrheic keratosis are two skin conditions that often show up around middle age. Since actinic keratosis lesions can become cancerous, it's best to get prompt treatment.
Keratosis refers to an overgrowth of the protein keratin in the skin. This excess keratin can appear in skin lesions that resemble patches, warts, or moles.
These two conditions may have similar names, but there's one major difference between the two: Actinic keratosis can become cancerous, while seborrheic keratosis cannot.
This makes it important to know how to tell these lesions apart. If you have a hard time recognizing the difference between the two, here's a quick rundown:
Actinic keratosis lesions often appear as rough, scaly patches that may show up in clusters. You'll often notice these patches in areas that get a lot of sun exposure, like your arms, hands, or face.
Seborrheic keratosis tends to show up as a single lesion. These growths tend to be small, oval, thick, and raised. They can have a mole- or wart-like appearance.
Learn more about these two conditions, along with a few key signs you may want to connect with a dermatologist for diagnosis and treatment.
Actinic keratosis
Since actinic keratosis is considered precancerous, it's important to identify and treat it.
Signs and symptoms
Actinic keratosis lesions:
may appear as thick, rough, or crusty patches; sometimes, you might feel the change in skin texture rather than see it
are usually smaller than 2 centimeters (cm)
often appear on body parts that get a lot of sun (like your face, neck, scalp, arms, or hands)
often appear as the same color as surrounding skin, if you have darker skin
may appear pink on lighter skin, or have a tan, brown or gray hue
might burn or itch
may show up as a horn-like growth
can appear as scaly or colorless patches on your lips
Causes
Actinic keratosis usually develops as a result of sun exposure over time.
Your chances of developing this skin condition increase if you:
are 50 or older
have light skin and eyes
tend to sunburn easily
have a history of frequent sun exposure or tanning bed use
have a weakened immune system
Treatment options
In the early stages, actinic keratosis is very treatable.
Your options for treatment include:
Electrocauterization: Electrocauterization involves burning the lesion with an electric current, which kills the affected skin cells.
Cryotherapy: Also called cryosurgery, this treatment involves applying a solution like liquid nitrogen to the affected area. This process freezes and kills the cells so the lesion scabs and falls off.
Curettage: This procedure involves scraping off the growth with a curette (a specialized surgical instrument). A dermatologist may recommend this in combination with electrosurgery.
Chemical peels: A dermatologist may apply a medical-grade chemical peel in-office to help remove the top layers of affected skin.
Topical medical therapy: Treatments like 5-fluorouracil can inflame and destroy the lesions.
Photodynamic therapy: This treatment involves the application of a photosensitive prescription medication solution (such as aminolevulinic acid) to the affected area. A dermatologist will then direct a red or blue laser light over the treated area to help destroy the actinic keratosis cells.
Seborrheic keratosis
These skin lesions are the most common form of benign lesion. If you notice them on your body, you might think they're just another mole or wart.
In some cases, though, they can resemble precancerous or cancerous growths, such as melanoma.
Here's how to recognize this type of skin growth.
Signs and symptoms
Seborrheic keratosis lesions:
may appear as round or oval-shaped, slightly raised growths
may seem 'stuck on' to your skin
often have a waxy or scale-like texture
generally show up on the face, chest, back, stomach, or shoulders
typically won't appear on the palms of your hands or the soles of your feet
often grow larger and thicker over time and can reach about 1 inch in diameter
often appear brown, black, white, or tan on light or dark skin
may cause itchiness or irritation, though these lesions usually aren't painful
Causes
Researchers still don't know exactly what causes seborrheic keratoses. The lesions don't seem to be viral, bacterial, or contagious.
That said, the following risk factors may increase your chances of developing these growths:
Age: Seborrheic keratosis is uncommon in people under age 20. It often shows up in middle age, and more lesions may appear as you get older.
Family history: They seems to run in families — the more relatives you have with these lesions, the more likely you may develop them yourself.
Pregnancy or hormone therapy: Seborrheic keratoses may appear during pregnancy or estrogen replacement therapy.
Frequent sun exposure: Some evidence suggests these lesions may appear more often on sun-exposed skin, but they can also develop on skin not regularly exposed to sun.
Lighter skin: These lesions more commonly affect people with lighter skin, but it's possible to still get them if you have darker skin.
Treatment options
Seborrheic keratosis often doesn't require treatment. But if you dislike the way your lesion looks or feels, you can always speak with a dermatologist or other doctor about removal.
If your lesion is actually a precancerous or cancerous growth, you'll need to have it removed. Your healthcare professional may recommend one of these procedures:
Cryosurgery
Electrosurgery and curettage
Shave excision: Your dermatologist may shave off a sample of the growth to send it to a lab for analysis.
Ablation: This procedure involves using a specialized laser to vaporize the growth.
Nitric acid-zinc solution: This treatment involves using a topical solution called nitrizinc complex. Emerging evidence suggests this treatment can safely shrink or totally eliminate the lesion, often within about 6 months.
When to get medical help
Any time your skin changes unexpectedly or you're concerned about a lesion, a good next step involves getting an assessment from a dermatologist or other medical professional.
Since actinic keratosis can sometimes turn into skin cancer, being vigilant about check-ups can help you lower your risk of skin cancer.
And even though seborrheic keratosis may not pose any danger to your health, it never hurts to have a professional confirm that your skin growth isn't cancerous.
As a general rule, you'll want to have a healthcare professional inspect your skin if:
You have a new growth.
The appearance of an existing growth changes.
A growth appears purple, blue or reddish or changes colors.
A growth has blurred or irregular borders.
A growth irritates you, bleeds, or causes pain.
Prevention tips
Frequent sun exposure can increase your chances of skin cancer, but these tips can help lower your risk:
Wear sunscreen every day — rain or shine, indoors or out. Opt for sunscreen that has a SPF rating of at least 30, with broad spectrum protection to block both UVA and UVB rays.
Avoid tanning beds.
Avoid spending time outside between 10 a.m. and 4 p.m. UV rays are strongest in the middle of the day.
Protect your skin from UV rays by wearing hats, long sleeves, and pants.
Bottom line
Both actinic keratosis and seborrheic keratosis are skin conditions that show up as growths. Since actinic keratosis lesions can potentially become cancerous, it helps to know how to tell the difference between the two.
Seborrheic keratosis are raised lesions that tend to have a round or oval shape, while actinic keratosis typically shows up as dry patches in areas of skin that get frequent sun exposure.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
The average healthcare stock has a yield of just 1.7%. Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. 10 stocks we like better than Medtronic › The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better. For example, Medtronic (NYSE: MDT) has a 3.3% yield today, and Alexandria Real Estate Equities (NYSE: ARE) is offering a yield of 7.4%. Here's what you need to know about each of these high-yield healthcare stocks. Medtronic makes medical devices. It is one of the largest competitors in the space, making products across the cardiovascular, neuroscience, medical surgical, and diabetes categories. It has a leading position in each of the areas in which it operates, and it operates on a global scale. That said, the last few years haven't been the best ones for the company. Innovation, which is highly important in the healthcare space, can be lumpy. And given Medtronic's size, the business has become a little cumbersome. Growth has stalled out, and profitability has come under pressure. Investors have focused on the negatives pushing the shares lower and the dividend yield up toward the high end of Medtronic's historical yield range. If you are a dividend investor that thinks in decades and not days, however, this is likely to be an investment opportunity. The company's innovation pipeline is starting to turn into new-product introductions. As new products gain traction, financial performance is likely to improve. And management has been working to streamline the business with cost cuts and a move to refocus on its most profitable operations. To that end, the company is set to spin off its lower-margin diabetes division in 2026. The move is expected to be immediately accretive to earnings, and the dividend policy isn't expected to change. All in, Medtronic is doing what it needs to do to get back on the growth path. And that should support continued dividend increases; the medical device maker only has two years to go before it hits Dividend King status (50+ years of annual dividend increases). June could be an opportune time to buy the stock hand over fist. Alexandria is a real estate investment trust (REIT), which seems pretty far away from healthcare. Its primary focus is on office properties, which also seems a bit removed from healthcare. The key here is that the REIT owns biomedical research facilities, which combine research space and office space in one property. Both are important to each other since the research takes place in specialized space, while the analysis of that research takes place in a normal office environment. Alexandria is one of the largest pure play medical research REITs you can buy. Alexandria counts some of the largest and most important medical research groups as tenants, from both the private side of the equation and the government side. However, like any landlord, the REIT's revenues will be impacted by the occupancy levels of its properties. And those rise and fall over time. Right now, occupancy is relatively weak, dropping to 91.7% at the end of the first quarter of 2025 from 94.6% at the end of 2024. Swings like this happen from time to time, but Wall Street is treating Alexandria as if its dividend is at a material risk of being cut. Only the funds from operations (FFO) payout ratio in the first quarter was a fairly strong 57%. There's room for adversity before a dividend cut would be in order. To be fair, office properties, and particularly highly specialized office properties, tend to have higher operating costs than other real estate assets. But it seems highly likely that Alexandria will manage its way through this weak patch and continue to extend its 15-year streak of annual dividend increases. For income lovers, this healthcare REIT is worth a deep dive in June. The average healthcare stock has an uninspiring dividend yield. But the average is made up of many different companies, some of which actually have very attractive dividend yields. That list includes industry-leading companies like Medtronic and Alexandria Real Estate. You might just want to pick up shares in one, or both, of these high yielders before June is over after you get to know them a little better. Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
I can think of so many things I love. I'll bet you can, too, and it's empowering
Most friendships include the occasional commiseration conversation. When we're young, those discussions center on homework or dating or parental interference. Eventually, we graduate to work disputes, financial woes and relationship friction. Alas, I've reached the age at which those conversations are constant rather than occasional, and the sources of angst generally are weight gain, politics and maladies. I pride myself on being a positive person, but sometimes waking up with aching knees and a bum shoulder can get depressing. Add to that a volatile stock market, sketchy medical bills and a car issue that may, or may not, be covered by warranty, and it's easy to wallow. Then a friend shared this quote: 'Focus on the things you are for, not the things you are against. Many people spend large chunks of their day thinking about what they hate. They are always telling you about something they dislike: this food, that subject, this political party, that co-worker. You are more than your frustrations. Build your identity around what you love.' It's attributed to James Clear, author of 'Atomic Habits,' though the Google could neither confirm nor deny its origins. Regardless, the message is empowering. So here goes, a few things I love: — I've taken up swimming for the second summer. I've worked my way up to swimming three times a week, one mile at a time. I've learned not to plan anything within two hours of a swim session, because it takes me that long to stop sweating. The thing I love most about swimming? I barely feel those achy joints anymore. — The babies have grown up and gone to college. The toddlers have toddlers of their own. That's how long my family has been gathering for our annual summer reunions. You'd think we'd be tired of them by now, but we're not. This year's trip is three weeks out, and the phone calls and group texts are in full swing as we plan meals, field trips and cabin assignments. I've also started stocking up on Publix BOGOs. (Yay for free Pop-Tarts!) — I recently started driving a new-to-me car that came equipped with Apple CarPlay. How have I driven four and a half decades without being able to shuffle my Pandora stations? Any drive is better when it features Billy Joel, Bonnie Raitt, Tyler Childers, the Partridge Family, Marcia Ball and Willie Nelson. It's also kind of awesome having an on-screen map that tells me when I'm 12 minutes from home. — After 21 years of marriage, my husband knows I'm dead calm when I've sliced off the tip of my finger while cutting potatoes. Blood-curdling screams are saved for flying roaches. — I have solved one of the world's greatest mysteries: Where errant socks go. Turns out we're not paranoid. The washing machine really does eat them. At least mine does. Socks like to get caught in the rubber gasket that seals my front-load washer. Sorry, pups. Didn't mean to wrongly accuse you. — And while we're talking about pups, my life is good. There are people who are literally allergic to dogs. — I love having friends who run the gamut when it comes to age, gender and political preferences. They make me smarter, and they make me laugh. They help me understand different perspectives, and they validate my beliefs. A life of homogeneity would be so dull. These are just a few of the things around which I want to build my identity. Now it's your turn. Will you focus on the things you love? Or will you let the things you hate define you? Suzy Fleming Leonard is a retired journalist who spent 25 years as a writer, editor and columnist at FLORIDA TODAY. Reach her at suzy@ This article originally appeared on Florida Today: When you fill your life with love, there's no room for hate | Leonard


E&E News
2 hours ago
- E&E News
NIH commits $10M for health studies at site of 2023 derailment
The National Institutes of Health announced funding Thursday for long-term health research in East Palestine, Ohio, where a train derailment spilled almost 2 million pounds of hazardous chemicals in 2023. Over the next five years, NIH will spend $10 million to study health problems being reported by East Palestine residents. 'This funding will enable the people of East Palestine to have the peace of mind that comes from knowing that any potential for long-term health effects will be studied by the scientists at the National Institutes of Health,' Ohio Gov. Mike DeWine (R) said in a news release. Advertisement East Palestine residents have expressed concern about hydrogen chloride and phosgene exposure after the controlled burning of seven rail cars following the accident. There are worries about asthma, headaches and respiratory irritation.